Real-world data on the use of secukinumab as treatment for moderate-to-severe psoriasis in Chinese patients. Huang H, Cai ML, Hong XJ, Zheng LJ, et al. Eur J Dermatol 2020 Oct 6. pii: ejd.2020.3878. doi: 10.1684/ejd.2020.3878.

Read + Share

Amedeo Smart

Independent Medical Education

Huang H, Cai ML, Hong XJ, Zheng LJ, et al. Real-world data on the use of secukinumab as treatment for moderate-to-severe psoriasis in Chinese patients. Eur J Dermatol 2020 Oct 6. pii: ejd.2020.3878. doi: 10.1684/ejd.2020.3878.
PMID: 33021475